Timothy Cabral Sells 7,500 Shares of Doximity (NYSE:DOCS) Stock

Doximity, Inc. (NYSE:DOCS – Get Free Report) Director Timothy Cabral sold 7,500 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $39.11, for a total value of $293,325.00. Following the transaction, the director owned 3,221 shares in the company, valued at $125,973.31. The trade was a 69.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Doximity Trading Down 4.3%

Shares of DOCS stock opened at $24.98 on Thursday. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51. The stock has a fifty day simple moving average of $21.51 and a two-hundred day simple moving average of $23.93. The stock has a market capitalization of $4.57 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 17.62 and a beta of 1.29.

Get Doximity alerts:

Doximity (NYSE:DOCS – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The firm had revenue of $156.62 million for the quarter. During the same quarter in the prior year, the business posted $0.36 EPS. The business’s quarterly revenue was up 7.3% on a year-over-year basis. Research analysts predict that Doximity, Inc. will post 0.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Doximity

Several institutional investors and hedge funds have recently bought and sold shares of DOCS. Northwestern Mutual Wealth Management Co. boosted its position in shares of Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares in the last quarter. Parallel Advisors LLC grew its stake in Doximity by 111.0% during the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock worth $60,000 after buying an additional 1,347 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Doximity by 937.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company’s stock valued at $66,000 after buying an additional 2,560 shares in the last quarter. Farther Finance Advisors LLC increased its position in Doximity by 35.7% during the 4th quarter. Farther Finance Advisors LLC now owns 1,539 shares of the company’s stock valued at $68,000 after buying an additional 405 shares in the last quarter. Finally, Leonteq Securities AG raised its stake in Doximity by 65.6% in the first quarter. Leonteq Securities AG now owns 2,912 shares of the company’s stock valued at $68,000 after buying an additional 1,154 shares during the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Jefferies Financial Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $51.00 to $19.00 in a research note on Thursday, May 14th. KeyCorp cut Doximity from an “overweight” rating to a “sector weight” rating in a research report on Thursday, May 14th. Weiss Ratings downgraded Doximity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, May 15th. Leerink Partners reduced their price target on Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. Finally, Bank of America reaffirmed an “underperform” rating and set a $20.00 price objective (down from $38.00) on shares of Doximity in a research report on Monday, June 29th. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $31.86.

Check Out Our Latest Report on Doximity

About Doximity

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Featured Articles

• Five stocks we like better than Doximity
• GE Vernova’s AI Power Boom Faces a Profit Test
• Cardinal Health Earnings: Can Perfection Get Priced In Twice?
• Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
• Legacy Jet Builders Stall While Embraer Accelerates to New Highs

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.